: Gene therapy has become a clinical reality as market-approved advanced therapy medicinal products for the treatment of distinct monogenetic diseases and B-cell malignancies. This Therapeutic Review aims to explain how progress in genome editing technologies offers the possibility to expand both therapeutic options and the types of diseases that will become treatable. To frame these impressive advances in the context of modern medicine, we incorporate examples from human clinical trials into our discussion on how genome editing will complement currently available strategies in gene therapy, which still mainly rely on gene addition strategies. Furthermore, safety considerations and ethical implications, including the issue of accessibility, are addressed as these crucial parameters will define the impact that gene therapy in general and genome editing in particular will have on how we treat patients in the near future.

A new age of precision gene therapy / Schambach, A.; Buchholz, C. J.; Torres-Ruiz, R.; Cichutek, K.; Morgan, M.; Trapani, I.; Buning, H.. - In: THE LANCET. - ISSN 1474-547X. - 403:10426(2024), pp. 568-582. [10.1016/S0140-6736(23)01952-9]

A new age of precision gene therapy

Trapani I.;
2024

Abstract

: Gene therapy has become a clinical reality as market-approved advanced therapy medicinal products for the treatment of distinct monogenetic diseases and B-cell malignancies. This Therapeutic Review aims to explain how progress in genome editing technologies offers the possibility to expand both therapeutic options and the types of diseases that will become treatable. To frame these impressive advances in the context of modern medicine, we incorporate examples from human clinical trials into our discussion on how genome editing will complement currently available strategies in gene therapy, which still mainly rely on gene addition strategies. Furthermore, safety considerations and ethical implications, including the issue of accessibility, are addressed as these crucial parameters will define the impact that gene therapy in general and genome editing in particular will have on how we treat patients in the near future.
2024
A new age of precision gene therapy / Schambach, A.; Buchholz, C. J.; Torres-Ruiz, R.; Cichutek, K.; Morgan, M.; Trapani, I.; Buning, H.. - In: THE LANCET. - ISSN 1474-547X. - 403:10426(2024), pp. 568-582. [10.1016/S0140-6736(23)01952-9]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/955902
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 22
  • ???jsp.display-item.citation.isi??? ND
social impact